Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

Phase 4

Completed

• Conditions: Intravitreal Injection Patients
• Interventions: Drug: Vigamox

• Registration Number: NCT00690313
• Lead Sponsor: Illinois Retina Associates

Brief Summary

Antibiotic eye drops are being used before and after intravitreal injections. Currently there is no study indicating the benefit of there usage or their dosage.

In this study we compare the efficacy of Vigamox eye drops (antibiotic)starting 3 days prior to the injection versus 1 day prior to intravitreal injection.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2008-05-30
• Study First Submitted QC: 2008-06-03
• Study First Posted: 2008-06-04
• Study Start: 2008-08
• Primary Completion: 2011-04
• Study Completion: 2011-04
• Status Verified: 2019-08
• Last Update Submitted: 2019-08-05
• Last Update Posted: 2019-08-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

• Patient who need intravitreal injections patients who are willing to participate in the study

Exclusion Criteria

• Patients who are allergic to Vigamox or who have taken any eye drops within the past 3 weeks

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Arm 1	Vigamox	Arm 1: receives Vigamox eye drops 3Xday for 3 days prior to intravitreal injection
Arm 2	Vigamox	Arm 2: receives Vigamox eye drops 3Xday for 1 day prior to intravitreal injection

Primary Outcome Measures

Name	Time	Method
Timed study	1 year

Trial Locations

Locations (1)

Illinois Retina Associates; 🇺🇸 Harvey, Illinois, United States